Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1235

1.

Non-atherosclerotic causes of acute coronary syndromes.

Waterbury TM, Tarantini G, Vogel B, Mehran R, Gersh BJ, Gulati R.

Nat Rev Cardiol. 2019 Oct 3. doi: 10.1038/s41569-019-0273-3. [Epub ahead of print] Review.

PMID:
31582839
2.

Gender Differences in Transfemoral Transcatheter Aortic Valve Replacement.

Vlastra W, Chandrasekhar J, Del Blanco BG, Tchétché D, de Brito FS Jr, Barbanti M, Kornowski R, Latib A, D'Onofrio A, Ribichini F, Baan J, Tijssen JGP, Moreno R, Dumonteil N, Tarasoutchi F, Sartori S, D'Errigo P, Tarantini G, Lunardi M, Orvin K, Pagnesi M, Berenguer A, Modine T, Dangas G, Mehran R, Piek JJ, Delewi R.

J Am Coll Cardiol. 2019 Sep 20. pii: S0735-1097(19)37669-7. doi: 10.1016/j.jacc.2019.09.015. [Epub ahead of print]

PMID:
31562908
3.

Five-Year Outcomes after PCI or CABG for Left Main Coronary Disease.

Stone GW, Kappetein AP, Sabik JF, Pocock SJ, Morice MC, Puskas J, Kandzari DE, Karmpaliotis D, Brown WM 3rd, Lembo NJ, Banning A, Merkely B, Horkay F, Boonstra PW, van Boven AJ, Ungi I, Bogáts G, Mansour S, Noiseux N, Sabaté M, Pomar J, Hickey M, Gershlick A, Buszman PE, Bochenek A, Schampaert E, Pagé P, Modolo R, Gregson J, Simonton CA, Mehran R, Kosmidou I, Généreux P, Crowley A, Dressler O, Serruys PW; EXCEL Trial Investigators.

N Engl J Med. 2019 Sep 28. doi: 10.1056/NEJMoa1909406. [Epub ahead of print]

PMID:
31562798
4.

Multidisciplinary treatment of thymic neuroendocrine tumors: surgery remains a key component.

Corsini EM, Mitchell KG, Sceusi EL, Mehran RJ, Rice DC, Sepesi B, Walsh GL, Swisher SG, Roth JA, Vaporciyan AA, Hofstetter WL, Antonoff MB.

J Thorac Dis. 2019 Aug;11(8):3391-3398. doi: 10.21037/jtd.2019.08.20.

5.

Antithrombotic Therapy in Patients with Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or with Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights from the AUGUSTUS Trial.

Windecker S, Lopes RD, Massaro T, Jones-Burton C, Granger CB, Aronson R, Heizer G, Goodman SG, Darius H, Jones WS, Aschermann M, Brieger D, Cura F, Engstrøm T, Fridrich V, Halvorsen S, Huber K, Kang HJ, Leiva-Pons JL, Lewis BS, Malaga G, Meneveau N, Merkely B, Milicic D, Morais J, Potpara TS, Raev D, Sabaté M, de Waha-Thiele S, Welsh RC, Xavier D, Mehran R, Alexander JH; AUGUSTUS Investigators.

Circulation. 2019 Sep 26. doi: 10.1161/CIRCULATIONAHA.119.043308. [Epub ahead of print]

PMID:
31557056
6.

Ticagrelor with or without Aspirin in High-Risk Patients after PCI.

Mehran R, Baber U, Sharma SK, Cohen DJ, Angiolillo DJ, Briguori C, Cha JY, Collier T, Dangas G, Dudek D, Džavík V, Escaned J, Gil R, Gurbel P, Hamm CW, Henry T, Huber K, Kastrati A, Kaul U, Kornowski R, Krucoff M, Kunadian V, Marx SO, Mehta SR, Moliterno D, Ohman EM, Oldroyd K, Sardella G, Sartori S, Shlofmitz R, Steg PG, Weisz G, Witzenbichler B, Han YL, Pocock S, Gibson CM.

N Engl J Med. 2019 Sep 26. doi: 10.1056/NEJMoa1908419. [Epub ahead of print]

PMID:
31556978
7.

Contrast-Associated Acute Kidney Injury. Reply.

Mehran R, Dangas GD, Weisbord SD.

N Engl J Med. 2019 Sep 26;381(13):1296-1297. doi: 10.1056/NEJMc1908879. No abstract available.

PMID:
31553855
8.

Hospitalization among Patients with Atrial Fibrillation and a Recent Acute Coronary Syndrome or Percutaneous Coronary Intervention Treated with Apixaban or Aspirin: Insights from the AUGUSTUS Trial.

Vora AN, Alexander JH, Wojdyla D, Aronson R, Granger CB, Darius H, Windecker S, Mehran R, Averkov O, Budaj AJ, Kong DF, Kobalava Z, Mehta RH, Mirza Z, Guimaraes PO, Parkhomenko A, Quadros A, Thiele H, Goodman SG, Lopes RD.

Circulation. 2019 Sep 25. doi: 10.1161/CIRCULATIONAHA.119.043754. [Epub ahead of print]

PMID:
31553201
9.

Time Trends of Perioperative Outcomes in Early-Stage Non-Small Cell Lung Cancer Resection Patients.

Shewale JB, Correa AM, Brown EL, Leon Novelo LG, Nyitray AG, Antonoff MB, Hofstetter WL, Mehran RJ, Rice DC, Walsh GL, Roth J, Vaporciyan AA, Swisher SG, Sepesi B.

Ann Thorac Surg. 2019 Sep 17. pii: S0003-4975(19)31400-6. doi: 10.1016/j.athoracsur.2019.08.018. [Epub ahead of print]

PMID:
31539514
10.

Minding the Microcirculation: Is it Worth the Effort?

Claessen BE, Cao D, Mehran R.

Circ Cardiovasc Interv. 2019 Sep;12(9):e008312. doi: 10.1161/CIRCINTERVENTIONS.119.008312. Epub 2019 Sep 6. No abstract available.

PMID:
31525079
11.

Procedural Strategies to Reduce the Incidence of Contrast-Induced Acute Kidney Injury During Percutaneous Coronary Intervention.

Almendarez M, Gurm HS, Mariani J Jr, Montorfano M, Brilakis ES, Mehran R, Azzalini L.

JACC Cardiovasc Interv. 2019 Oct 14;12(19):1877-1888. doi: 10.1016/j.jcin.2019.04.055. Epub 2019 Sep 11. Review.

PMID:
31521648
12.

Relationship Between Stent Diameter, Platelet Reactivity, and Thrombotic Events After Percutaneous Coronary Artery Revascularization.

Redfors B, Chen S, Généreux P, Witzenbichler B, Weisz G, Stuckey TD, Maehara A, McAndrew T, Mehran R, Ben-Yehuda O, Kirtane AJ, Stone GW.

Am J Cardiol. 2019 Nov 1;124(9):1363-1371. doi: 10.1016/j.amjcard.2019.07.054. Epub 2019 Aug 13.

PMID:
31493829
13.

Impact of stent diameter on outcomes following percutaneous coronary intervention with second-generation drug-eluting stents: Results from a large single-center registry.

Plitt A, Claessen BE, Sartori S, Baber U, Chandrasekhar J, Aquino M, Vijay P, Elsayed S, Kovacic JC, Sweeny J, Barman N, Moreno P, Krishnan P, Demopoulos A, Dangas G, Kini AS, Mehran R, Sharma SK.

Catheter Cardiovasc Interv. 2019 Sep 6. doi: 10.1002/ccd.28488. [Epub ahead of print]

PMID:
31490029
14.

The REMEDEE trial: 5-Year results on a novel combined sirolimus-eluting and endothelial progenitor cells capturing stent.

Haude M, Lee SWL, Worthley SG, Silber S, Verheye S, Rosli MA, Botelho R, Sim KH, Abizaid A, Mehran R; REMEDEE Trial Investigators.

Catheter Cardiovasc Interv. 2019 Sep 5. doi: 10.1002/ccd.28483. [Epub ahead of print]

PMID:
31489742
15.

Feasibility of measuring patient-reported health status at time of percutaneous coronary intervention: Results from a single-center quality-improvement initiative.

Farhan S, Baber U, Vogel B, Aquino M, Giustino G, Chandrasekhar J, Sorrentino S, Guedeney P, Manzanilla G, Bunal N, Rassouli M, Barman N, Sweeny J, Khan A, Dangas G, Mehran R, Kini A, Sharma SK.

Eur J Prev Cardiol. 2019 Sep 3:2047487319874150. doi: 10.1177/2047487319874150. [Epub ahead of print] No abstract available.

PMID:
31480872
16.

Association Between Hypertension, Platelet Reactivity, and the Risk of Adverse Events After Percutaneous Coronary Intervention (From the ADAPT-DES Study).

Redfors B, Chen S, Ben-Yehuda O, Huang X, Witzenbichler B, Weisz G, Liu Y, Brodie BR, Rinaldi MJ, Neumann FJ, Metzger DC, Henry TD, Cox DA, Duffy PL, Mazzaferri EL Jr, Mehran R, Stuckey TD, Kirtane AJ, Stone GW.

Am J Cardiol. 2019 Nov 1;124(9):1380-1388. doi: 10.1016/j.amjcard.2019.07.044. Epub 2019 Aug 7.

PMID:
31477234
17.

Defining Device Success for Percutaneous Coronary Intervention Trials: A Position Statement from the European Association of Percutaneous Cardiovascular Interventions of the European Society of Cardiology.

Chang CC, Kogame N, Onuma Y, Byrne RA, Capodanno D, Windecker S, Morel MA, Cutlip DE, Krucoff MW, Stone GW, Lansky AJ, Mehran R, Spitzer E, Fraser AG, Baumbach A, Serruys PW.

EuroIntervention. 2019 Sep 3. pii: EIJ-D-19-00552. doi: 10.4244/EIJ-D-19-00552. [Epub ahead of print]

18.

Complete Revascularization with Multivessel PCI for Myocardial Infarction.

Mehta SR, Wood DA, Storey RF, Mehran R, Bainey KR, Nguyen H, Meeks B, Di Pasquale G, López-Sendón J, Faxon DP, Mauri L, Rao SV, Feldman L, Steg PG, Avezum Á, Sheth T, Pinilla-Echeverri N, Moreno R, Campo G, Wrigley B, Kedev S, Sutton A, Oliver R, Rodés-Cabau J, Stanković G, Welsh R, Lavi S, Cantor WJ, Wang J, Nakamya J, Bangdiwala SI, Cairns JA; COMPLETE Trial Steering Committee and Investigators.

N Engl J Med. 2019 Oct 10;381(15):1411-1421. doi: 10.1056/NEJMoa1907775. Epub 2019 Sep 1.

PMID:
31475795
19.

Persistent Opioid Use Among The Elderly After Lung Resection: A SEER-Medicare Study.

Nelson DB, Niu J, Mitchell KG, Sepesi B, Hofstetter WL, Antonoff MB, Giordano SH, Mehran RJ, Rice DC.

Ann Thorac Surg. 2019 Aug 22. pii: S0003-4975(19)31216-0. doi: 10.1016/j.athoracsur.2019.06.095. [Epub ahead of print]

PMID:
31445908
20.

Preoperative Carbohydrate Loading in Patients Undergoing Thoracic Surgery: A Quality-Improvement Project.

Pachella LA, Mehran RJ, Curtin K, Schneider SM.

J Perianesth Nurs. 2019 Aug 21. pii: S1089-9472(19)30136-4. doi: 10.1016/j.jopan.2019.05.007. [Epub ahead of print]

PMID:
31445819
21.

Reply: DAPT Cessation and MACE in Elderly Patients: What Is the Optimal Regimen and Duration?

Joyce L, Baber U, Mehran R.

JACC Cardiovasc Interv. 2019 Aug 26;12(16):1627-1628. doi: 10.1016/j.jcin.2019.06.041. No abstract available.

PMID:
31439345
22.

Return to intended oncologic treatment after surgery for malignant pleural mesothelioma.

Nelson DB, Rice DC, Mitchell KG, Tsao AS, Gomez DR, Sepesi B, Mehran RJ.

J Thorac Cardiovasc Surg. 2019 Sep;158(3):924-929. doi: 10.1016/j.jtcvs.2019.02.129. Epub 2019 Apr 16.

PMID:
31430846
23.

Local failure after stereotactic body radiation therapy or wedge resection for colorectal pulmonary metastases.

Nelson DB, Tayob N, Nguyen QN, Erasmus J, Mitchell KG, Hofstetter WL, Sepesi B, Antonoff MB, Mehran RJ.

J Thorac Cardiovasc Surg. 2019 Oct;158(4):1234-1241.e16. doi: 10.1016/j.jtcvs.2019.02.133. Epub 2019 May 11.

PMID:
31395367
24.

Geographical Variations in Patterns of DAPT Cessation and Two-Year PCI Outcomes: Insights from the PARIS Registry.

Vogel B, Chandrasekhar J, Baber U, Mastoris I, Sartori S, Aquino M, Krucoff MW, Moliterno DJ, Henry TD, Weisz G, Gibson CM, Iakovou I, Kini AS, Farhan S, Sorrentino S, Faggioni M, Colombo A, Steg PG, Witzenbichler B, Chieffo A, Cohen DJ, Stuckey T, Ariti C, Dangas GD, Pocock S, Mehran R.

Thromb Haemost. 2019 Oct;19(10):1704-1711. doi: 10.1055/s-0039-1693463. Epub 2019 Jul 31.

PMID:
31365942
25.

Impella support and acute kidney injury during high-risk percutaneous coronary intervention: The Global cVAD Renal Protection Study.

Flaherty MP, Moses JW, Westenfeld R, Palacios I, O'Neill WW, Schreiber TL, Lim MJ, Kaki A, Ghiu I, Mehran R.

Catheter Cardiovasc Interv. 2019 Jul 29. doi: 10.1002/ccd.28400. [Epub ahead of print]

PMID:
31355987
26.

Design and rationale of the COMPLETE trial: A randomized, comparative effectiveness study of complete versus culprit-only percutaneous coronary intervention to treat multivessel coronary artery disease in patients presenting with ST-segment elevation myocardial infarction.

Mehta SR, Wood DA, Meeks B, Storey RF, Mehran R, Bainey KR, Nguyen H, Bangdiwala SI, Cairns JA; COMPLETE Trial Steering Committee and Investigators.

Am Heart J. 2019 Sep;215:157-166. doi: 10.1016/j.ahj.2019.06.006. Epub 2019 Jun 18.

PMID:
31326681
27.

Morbidity following salvage esophagectomy for squamous cell carcinoma: the MD Anderson experience.

Mitchell KG, Nelson DB, Corsini EM, Vaporciyan AA, Antonoff MB, Mehran RJ, Rice DC, Roth JA, Sepesi B, Walsh GL, Bhutani MS, Maru DM, Wu CC, Nguyen QN, Ajani JA, Swisher SG, Hofstetter WL.

Dis Esophagus. 2019 Jul 17. pii: doz067. doi: 10.1093/dote/doz067. [Epub ahead of print]

PMID:
31313820
28.

Colorectal cancer mutations are associated with survival and recurrence after pulmonary metastasectomy.

Corsini EM, Mitchell KG, Mehran RJ, Rice DC, Sepesi B, Walsh GL, Swisher SG, Roth JA, Hofstetter WL, Vaporciyan AA, Morris VK, Antonoff MB.

J Surg Oncol. 2019 Sep;120(4):729-735. doi: 10.1002/jso.25630. Epub 2019 Jul 9.

PMID:
31290159
29.

Impact of Diabetes Mellitus in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents.

Baber U, Stefanini GG, Giustino G, Stone GW, Leon MB, Sartori S, Aquino M, Steg PG, Windecker S, Wijns W, Serruys PW, Valgimigli M, Morice MC, Camenzind E, Weisz G, Smits PC, Kandzari DE, von Birgelen C, Dangas GD, Galatius S, Jeger RV, Kimura T, Mikhail GW, Itchhaporia D, Mehta L, Ortega R, Kim HS, Kastrati A, Chieffo A, Mehran R.

Circ Cardiovasc Interv. 2019 Jul;12(7):e007734. doi: 10.1161/CIRCINTERVENTIONS.118.007734. Epub 2019 Jul 10.

PMID:
31288561
30.

Tumor characteristics associated with engraftment of patient-derived non-small cell lung cancer xenografts in immunocompromised mice.

Chen Y, Zhang R, Wang L, Correa AM, Pataer A, Xu Y, Zhang X, Ren C, Wu S, Meng QH, Fujimoto J, Jensen VB, Antonoff MB, Hofstetter WL, Mehran RJ, Pisimisis G, Rice DC, Sepesi B, Vaporciyan AA, Walsh GL, Swisher SG, Roth JA, Heymach JV, Fang B.

Cancer. 2019 Nov 1;125(21):3738-3748. doi: 10.1002/cncr.32366. Epub 2019 Jul 9.

PMID:
31287557
31.

Glutathione reductase (GSR) gene deletion and chromosome 8 aneuploidy in primary lung cancers detected by fluorescence in situ hybridization.

Baity M, Wang L, Correa AM, Zhang X, Zhang R, Pataer A, Wu S, Meng QH, Antonoff MB, Hofstetter WL, Mehran RJ, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Zhao M, Gu J, Fang B.

Am J Cancer Res. 2019 Jun 1;9(6):1201-1211. eCollection 2019.

32.

Management of Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI: JACC State-of-the-Art Review.

Capodanno D, Huber K, Mehran R, Lip GYH, Faxon DP, Granger CB, Vranckx P, Lopes RD, Montalescot G, Cannon CP, Ten Berg J, Gersh BJ, Bhatt DL, Angiolillo DJ.

J Am Coll Cardiol. 2019 Jul 9;74(1):83-99. doi: 10.1016/j.jacc.2019.05.016. Review.

PMID:
31272556
33.

Negative Risk Markers for Cardiovascular Events in the Elderly.

Mortensen MB, Fuster V, Muntendam P, Mehran R, Baber U, Sartori S, Falk E.

J Am Coll Cardiol. 2019 Jul 9;74(1):1-11. doi: 10.1016/j.jacc.2019.04.049.

PMID:
31272534
34.

Efficacy and safety of alirocumab and evolocumab: a systematic review and meta-analysis of randomized controlled trials.

Guedeney P, Giustino G, Sorrentino S, Claessen BE, Camaj A, Kalkman DN, Vogel B, Sartori S, De Rosa S, Baber U, Indolfi C, Montalescot G, Dangas GD, Rosenson RS, Pocock SJ, Mehran R.

Eur Heart J. 2019 Jul 3. pii: ehz430. doi: 10.1093/eurheartj/ehz430. [Epub ahead of print]

PMID:
31270529
36.

Intercostal nerve blockade for thoracic surgery with liposomal bupivacaine: the devil is in the details.

Martin LW, Mehran RJ.

J Thorac Dis. 2019 May;11(Suppl 9):S1202-S1205. doi: 10.21037/jtd.2019.03.62. No abstract available.

37.

Corrigendum to "Safety and efficacy of the COMBO bio-engineered stent in an all-comer PCI cohort: 1-year final clinical outcomes from the MASCOT post-marketing registry" [Int. J. Cardiol. 283 (2019) 67-72].

Colombo A, Chandrasekhar J, Aquino M, Ong TK, Sartori S, Baber U, Lee M, Iniguez A, Hajek P, Borisov B, Atzev B, Heijer PD, Coufal Z, Hudec M, Mates M, Snyder C, Moalem K, Morrell D, Elmore F, Rowland S, Mehran R; MASCOT Investigators.

Int J Cardiol. 2019 Oct 1;292:285. doi: 10.1016/j.ijcard.2019.04.075. Epub 2019 Jun 18. No abstract available.

PMID:
31227412
38.

Safety and Efficacy of Antithrombotic Strategies in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Network Meta-analysis of Randomized Controlled Trials.

Lopes RD, Hong H, Harskamp RE, Bhatt DL, Mehran R, Cannon CP, Granger CB, Verheugt FWA, Li J, Ten Berg JM, Sarafoff N, Gibson CM, Alexander JH.

JAMA Cardiol. 2019 Jun 19. doi: 10.1001/jamacardio.2019.1880. [Epub ahead of print]

PMID:
31215979
39.

Rationale and design of the Onyx ONE global randomized trial: A randomized controlled trial of high-bleeding risk patients after stent placement with 1 month of dual antiplatelet therapy.

Kedhi E, Latib A, Abizaid A, Kandzari D, Kirtane AJ, Mehran R, Price MJ, Simon D, Worthley S, Zaman A, Brar S, Liu M, Stone GW, Windecker S.

Am Heart J. 2019 Aug;214:134-141. doi: 10.1016/j.ahj.2019.04.017. Epub 2019 May 6.

40.

Updated Expert Consensus Statement on Platelet Function and Genetic Testing for Guiding P2Y12 Receptor Inhibitor Treatment in Percutaneous Coronary Intervention.

Sibbing D, Aradi D, Alexopoulos D, Ten Berg J, Bhatt DL, Bonello L, Collet JP, Cuisset T, Franchi F, Gross L, Gurbel P, Jeong YH, Mehran R, Moliterno DJ, Neumann FJ, Pereira NL, Price MJ, Sabatine MS, So DYF, Stone GW, Storey RF, Tantry U, Trenk D, Valgimigli M, Waksman R, Angiolillo DJ.

JACC Cardiovasc Interv. 2019 Aug 26;12(16):1521-1537. doi: 10.1016/j.jcin.2019.03.034. Epub 2019 Jun 12. Review.

PMID:
31202949
41.

Incidence, predictors and impact of stroke on mortality among patients with acute coronary syndromes following percutaneous coronary intervention-Results from the PROMETHEUS registry.

Chandiramani R, Chen H, Aoi S, Giustino G, Claessen B, Sartori S, Aquino M, Sorrentino S, Cao D, Goel R, Kini A, Rao S, Weintraub W, Henry TD, Kapadia S, DeFranco A, Muhlestein JB, Toma C, Effron MB, Keller S, Baker BA, Pocock S, Baber U, Mehran R.

Catheter Cardiovasc Interv. 2019 Jun 14. doi: 10.1002/ccd.28369. [Epub ahead of print]

PMID:
31197962
42.

Stent Expansion and Endothelial Shear Stress in Bifurcation Lesions.

Okamoto N, Vengrenyuk Y, Bhatheja S, Chamaria S, Khan A, Gupta E, Kapur V, Barman N, Hasan C, Sweeny J, Baber U, Mehran R, Narula J, Sharma SK, Kini AS.

Circ Cardiovasc Interv. 2019 Jun;12(6):e007911. doi: 10.1161/CIRCINTERVENTIONS.119.007911. Epub 2019 Jun 14. No abstract available.

PMID:
31195824
43.

Derivation and external validation of a novel risk score for prediction of 30-day mortality after percutaneous coronary intervention.

Brener SJ, Leon MB, Serruys PW, Smits PC, von Birgelen C, Mehran R, Kirtane AJ, Witzenbichler B, Rinaldi MJ, Metzger DC, Mazzaferri EL Jr, Zhang Z, Stone GW; Collaborators.

EuroIntervention. 2019 Aug 9;15(6):e551-e557. doi: 10.4244/EIJ-D-19-00262.

44.

Defining the role of adjuvant radiotherapy for malignant pleural mesothelioma: a propensity-matched landmark analysis of the National Cancer Database.

Nelson DB, Rice DC, Mitchell KG, Tsao AS, Vaporciyan AA, Antonoff MB, Hofstetter WL, Walsh GL, Swisher SG, Roth JA, Gomez DR, Mehran RJ, Sepesi B.

J Thorac Dis. 2019 Apr;11(4):1269-1278. doi: 10.21037/jtd.2019.04.27.

45.

ST-segment elevation myocardial infarction.

Vogel B, Claessen BE, Arnold SV, Chan D, Cohen DJ, Giannitsis E, Gibson CM, Goto S, Katus HA, Kerneis M, Kimura T, Kunadian V, Pinto DS, Shiomi H, Spertus JA, Steg PG, Mehran R.

Nat Rev Dis Primers. 2019 Jun 6;5(1):39. doi: 10.1038/s41572-019-0090-3. Review.

PMID:
31171787
46.

Persistent opioid use is associated with worse survival after lobectomy for stage I non-small cell lung cancer.

Nelson DB, Cata JP, Niu J, Mitchell KG, Vaporciyan AA, Antonoff MB, Hofstetter WL, Giordano SH, Sepesi B, Mehran RJ, Rice DC.

Pain. 2019 Oct;160(10):2365-2373. doi: 10.1097/j.pain.0000000000001630.

PMID:
31149979
47.

Contrast-Associated Acute Kidney Injury.

Mehran R, Dangas GD, Weisbord SD.

N Engl J Med. 2019 May 30;380(22):2146-2155. doi: 10.1056/NEJMra1805256. Review. No abstract available.

PMID:
31141635
48.

Dual-Antiplatelet Therapy Cessation and Cardiovascular Risk in Relation to Age: Analysis From the PARIS Registry.

Joyce LC, Baber U, Claessen BE, Sartori S, Chandrasekhar J, Cohen DJ, Henry TD, Ariti C, Dangas G, Faggioni M, Aoi S, Gibson CM, Aquino M, Krucoff MW, Vogel B, Moliterno DJ, Sorrentino S, Colombo A, Chieffo A, Kini A, Guedeney P, Witzenbichler B, Weisz G, Steg PG, Pocock S, Mehran R.

JACC Cardiovasc Interv. 2019 May 27;12(10):983-992. doi: 10.1016/j.jcin.2019.02.033.

PMID:
31122354
49.

Transfemoral TAVR in Nonagenarians: From the CENTER Collaboration.

Vlastra W, Chandrasekhar J, Vendrik J, Gutierrez-Ibanes E, Tchétché D, de Brito FS Jr, Barbanti M, Kornowski R, Latib A, D'Onofrio A, Ribichini F, Baan J, Tijssen JGP, Pan M, Dumonteil N, Mangione JA, Sartori S, D'Errigo P, Tarantini G, Lunardi M, Orvin K, Pagnesi M, Sanchez Gila J, Modine T, Dangas G, Mehran R, Piek JJ, Delewi R.

JACC Cardiovasc Interv. 2019 May 27;12(10):911-920. doi: 10.1016/j.jcin.2019.02.031.

PMID:
31122347
50.

Impact of percutaneous closure device type on vascular and bleeding complications after TAVR: A post hoc analysis from the BRAVO-3 randomized trial.

Power D, Schäfer U, Guedeney P, Claessen BE, Sartori S, Sorrentino S, Lefèvre T, Kupatt C, Tchetche D, Dumonteil N, Webb JG, Colombo A, Windecker S, Ten Berg JM, Hildick-Smith D, Boekstegers P, Linke A, Tron C, Van Belle E, Asgar AW, Jeger R, Sardella G, Hink U, Husser O, Grube E, Lechthaler I, Wijngaard P, Anthopoulos P, Deliargyris EN, Bernstein D, Hengstenberg C, Mehran R, Dangas GD.

Catheter Cardiovasc Interv. 2019 Jun 1;93(7):1374-1381. doi: 10.1002/ccd.28295. Epub 2019 May 22.

PMID:
31116908

Supplemental Content

Loading ...
Support Center